aid: attovia
name: Attovia Therapeutics
description: 'Attovia Therapeutics is a clinical-stage biopharmaceutical company in San
  Carlos, California, founded in 2022 and developing next-generation precision biologics
  for immune-mediated diseases. Its proprietary ATTOBODY platform is a modular protein
  design technology built on biparatopic nanobody scaffolds, used to engineer multispecific
  biologics that inhibit two, three, or four disease-driving pathways from a single molecule
  while targeting improved selectivity, stability, and less frequent dosing than existing
  therapies. The lead program ATTO-1310 is an anti-IL-31 candidate in Phase 1 for chronic
  pruritus and high-itch atopic dermatitis; ATTO-2306 (IL-31 x IL-13) and ATTO-1091 (TL1A
  x IL-23p19 x integrin alpha-4-beta-7, for inflammatory bowel disease) are in IND-enabling
  studies, alongside discovery-stage programs in rheumatology, IBD, and respiratory disease.
  The company raised a $105M Series B led by Goldman Sachs Alternatives and listed on Nasdaq
  as ATTO in August 2026, raising $289M. Attovia publishes no public API, developer portal,
  SDK, or machine-readable specification — its product is therapeutics, not software.'
image: https://www.attovia.com/wp-content/uploads/2023/09/Attovia-logo.svg
url: https://raw.githubusercontent.com/api-evangelist/attovia/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: no-api-surface
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Biopharmaceutical
- Life Sciences
- Immunology
- Therapeutics
- Drug Discovery
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/attovia-domain-security.yml
- type: LLMsTxt
  url: llms/attovia-llms.txt
- type: Website
  url: https://www.attovia.com/
- type: TermsOfService
  url: https://www.attovia.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.attovia.com/privacy-policy/
- type: Support
  url: https://www.attovia.com/contact-us/
- type: SecondaryMarket
  url: https://forgeglobal.com/attovia_stock/
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Attovia is a clinical-stage biopharmaceutical company whose product is multispecific
    antibody therapeutics, not software — its entire public web presence is a ten-page
    WordPress corporate site (platform, pipeline, team, careers, contact, legal) with no
    developer section, and api/developers/developer/docs.attovia.com do not resolve in DNS.
  evidence:
    - url: https://www.attovia.com/openapi.json
      status: 404
    - url: https://www.attovia.com/.well-known/agent-card.json
      status: 404
    - url: https://www.attovia.com/llms.txt
      status: 404
    - url: https://www.attovia.com/page-sitemap.xml
      status: 200
  checked: '2026-08-06'